No article text was recorded for this version.
pharmacogenomic sensitivity mapping
Version 1 of 136 papers36 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons
- Blog: Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma
- Blog: Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15
- Blog: Pan-cancer analysis identifies venous thromboembolism-related genes F3, PLAT, and C1S as potential prognostic biomarkers for glioblastoma and lower grade glioma
- Blog: Abstracts from the ASENT 2005 Annual Meeting March 3–5, 2005
- Blog: 5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia
- Blog: Molecular Integrative Clustering of Asian Gastric Cell Lines Revealed Two Distinct Chemosensitivity Clusters
- Blog: Expression of hub genes of endothelial cells in glioblastoma-A prognostic model for GBM patients integrating single-cell RNA sequencing and bulk RNA sequencing
- Blog: Prognosis and immunological characteristics of HDAC family in pan-cancer through integrative multi-omic analysis
- Blog: A comprehensive tool for tumor precision medicine with pharmaco-omics data analysis
- Blog: Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer
- Blog: Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcoma
- Blog: Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6, 700 cancer genomes
- Blog: A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer
- Blog: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
- Blog: Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines
- Blog: Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma
- Blog: Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer
- Blog: Identification of disease treatment mechanisms through the multiscale interactome
- Blog: Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing’s sarcoma
- Blog: Transcriptome Sequencing Unveils a Molecular-Stratification-Predicting Prognosis of Sarcoma Associated with Lipid Metabolism
- Blog: Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma
- Blog: Dysregulation of SAA1, TUBA8 and Monocytes Are Key Factors in Ankylosing Spondylitis With Femoral Head Necrosis
- Blog: Immunological role and prognostic value of the SKA family in pan-cancer analysis
- Blog: A Five Glutamine-Associated Signature Predicts Prognosis of Prostate Cancer and Links Glutamine Metabolism with Tumor Microenvironment
- Blog: Effects of Bushen-Jiangya granules on blood pressure and pharmacogenomic evaluation in low-to-medium-risk hypertensive patients: study protocol for a randomized double-blind controlled trial
- Blog: Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma
- Blog: A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma
- Blog: Transcriptional expressions of hsa-mir-183 predicted target genes as independent indicators for prognosis in bladder urothelial carcinoma
- Blog: Multidimensional analysis suggests that ZNF433 is a promising biomarker for the diagnosis and prognosis of human cancers
- Blog: Modeling cellular response in large-scale radiogenomic databases to advance precision radiotherapy
- Blog: Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor
- Blog: N6-Methylandenosine-related lncRNAs as potential biomarkers for predicting prognosis and the immunotherapy response in pancreatic cancer
- Blog: Bayesian Robust Learning in Chain Graph Models for Integrative Pharmacogenomics
- Blog: Construction of a Prognostic Model based on CSC-related Genes in Patients with Colorectal Cancer
- Blog: MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma
History & citation
Current · Permanent link
- This direction split from Transcriptomic Inference of Cancer Drug Sensitivity (67% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_pharmacogenomic_sensitivity_mapping_1efbb30b,
title = {pharmacogenomic sensitivity mapping},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/pharmacogenomic-sensitivity-mapping/rdr_1efbb30bc9f94526874bd845535e463f},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_pharmacogenomic_sensitivity_mapping_1efbb30b_v1,
title = {pharmacogenomic sensitivity mapping},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/pharmacogenomic-sensitivity-mapping/rdr_1efbb30bc9f94526874bd845535e463f/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}